MedTrace Logo

Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions

NCT05097157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2022-06-09

Study results available
· View outcomes & findings →

Summary

Subjects are to be enrolled in this clinical study if they are 18 - 55 years old. Up to 120 subjects will be enrolled at multiple study centers. Subjects may receive up to 5 treatments for a wide array of dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.

Conditions

  • Wrinkle
  • Fine Lines
  • Crepey Skin
  • Acne Scars
  • Acne
  • Enlarged Pores
  • Stretch Marks
  • Loose Skin

Interventions

DEVICE

Potenza

Subjects are treated with the Potenza™ device if they present with conditions such as, but not limited to: wrinkles, fine lines, crepey skin, acne scars, active acne, enlarged pores, stretch marks, or loose skin on the face, neck and/or body.

Sponsors & Collaborators

  • Cynosure, Inc.

    lead INDUSTRY

Principal Investigators

  • Jennifer Civiok · Cynosure, Inc.

  • Sean Doherty · Cynosure, Inc.

  • Robert Weiss · Maryland Dermatology Laser, Skin, & Vein Institute, LLC

  • Emil Tanghetti · Center for Dermatology and Laser Surgery

  • David McDaniel · McDaniel Institute of Anti-Aging Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-03
Primary Completion
2021-04-12
Completion
2021-06-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05097157 on ClinicalTrials.gov